ArticleClinical and translational science2021

Edoxaban for the Long-Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

Giuseppe Camporese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.